Longview Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Hold
1,598
1.12% 16
2026
Q1
$1.47M Hold
1,598
0.9% 18
2025
Q4
$1.72M Hold
1,598
1.17% 17
2025
Q3
$1.22M Hold
1,598
0.87% 20
2025
Q2
$1.25M Sell
1,598
-16
-1% -$12.4K 1.06% 18
2025
Q1
$1.33M Buy
1,614
+8
+0.5% +$6.66K 1.14% 18
2024
Q4
$1.24M Buy
1,606
+8
+0.5% +$6.62K 0.98% 19
2024
Q3
$1.42M Sell
1,598
-40
-2% -$36K 1.04% 19
2024
Q2
$1.48M Hold
1,638
1.13% 18
2024
Q1
$1.27M Hold
1,638
0.96% 19
2023
Q4
$955K Buy
+1,638
New +$956K 0.77% 22

Other funds holding LLY

Longview Financial Advisors's LLY Position: Q2 2026 in Review

Longview Financial Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,598 shares worth $1.92M. The position accounts for 1.12% of the portfolio, ranked #16.

Longview Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Longview Financial Advisors held 1,598 shares of Eli Lilly worth $1.92M as of Q2 2026.
  • Longview Financial Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.12% of Longview Financial Advisors's portfolio in Q2 2026, its #16 holding.
  • Longview Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Longview Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.